Skip to main navigation Skip to main content
  • KSBMR

JBM : Journal of Bone Metabolism

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

2
results for

"Seeyoun Lee"

Article category

Keywords

Publication year

Authors

"Seeyoun Lee"

Original Articles

Risk of Osteoporotic Fracture in Patients with Breast Cancer: Meta-Analysis
Seeyoun Lee, Jun-Il Yoo, Young-Kyun Lee, Jung-Wee Park, Seokhyung Won, Jiung Yeom, Jin Woo Im, Seok Min Lim, Yong-Chan Ha, Kyung-Hoi Koo
J Bone Metab 2020;27(1):27-34.
Published online February 29, 2020
DOI: https://doi.org/10.11005/jbm.2020.27.1.27
Background

The fracture risk induced by anti-estrogen therapy in patients with breast cancer remains controversial. The aim of this study was to perform a meta-analysis and systematic review to evaluate the risk of osteoporotic fracture in patients with breast cancer.

Methods

A systematic search was performed to identify studies that included any osteoporotic fracture (hip fracture and vertebral fracture) in patients breast cancer. Main outcome measures were occurrence and risk of osteoporotic fractures including hip and vertebral fractures in patients and controls.

Results

A systematic search yielded a total of 4 studies that included osteoporotic fracture outcomes in patients with breast cancer. Meta-analysis showed a higher risk of osteoporotic fracture in patients with breast cancer. Analysis of these 4 studies involving a total of 127,722 (23,821 cases and 103,901 controls) patients showed that the incidence of osteoporotic fractures was higher in the breast cancer group than in the control group. The pooled estimate of crude relative risk for osteoporotic fracture was 1.35 (95% confidence interval, 1.29–1.42; P<0.001).

Conclusions

Although studies were limited by a small number, results suggested a possible association between anti-estrogen therapy and increased risk of osteoporotic fractures in patients with breast cancer.

Citations

Citations to this article as recorded by  Crossref logo
  • 1. Fragility fracture risk prediction using quantitative magnetic resonance and Vertebral Bone Quality scoring beyond density
    Sanjith Manian, Arunagiri Gunasekar, Naveen Jeyaraman, Arulkumar Nallakumarasamy, Sathish Muthu, Madhan Jeyaraman
    World Journal of Methodology.2026;[Epub]     CrossRef
  • 2. Survivorship Issues in Older Adults with Breast Cancer
    Claire R. Morton, Eliza H. Lorentzen, Christina A. Minami
    Current Breast Cancer Reports.2025;[Epub]     CrossRef
  • 3. Bone Mineral Density in Black South African Women Newly Diagnosed With Breast Cancer Living With and Without HIV
    Lindor Qunaj, Maureen Joffe, Alfred I. Neugut, Lisa K. Micklesfield
    JCO Global Oncology.2025;[Epub]     CrossRef
  • 4. Enhancing Timeliness and Compliance of Osteoporosis Care in Oncology: Evidence from a Dedicated Bone Health Service
    William Balzi, Valentina Danesi, Andrea Roncadori, Ilaria Massa, Roberta Maltoni, Nicola Gentili, Martina Cavallucci, Alice Andalò, Laura Ridolfi, Venetia Zavoiu, Maria Cristina Focherini, Raffaele Giannini, Enrico Campadelli, Stefano Tamberi, Sebastiano
    Journal of Clinical Medicine.2025; 14(18): 6564.     CrossRef
  • 5. Risk of fractures in half a million survivors of 20 cancers: a population-based matched cohort study using linked English electronic health records
    Eva Buzasi, Helena Carreira, Garth Funston, Kathryn E Mansfield, Harriet Forbes, Helen Strongman, Krishnan Bhaskaran
    The Lancet Healthy Longevity.2024; 5(3): e194.     CrossRef
  • 6. Efficacy of a single 5 mg zoledronic acid infusion in preventing bone loss and fracture in postmenopausal women with breast cancer
    Han-Sang Baek, Kabsoo shin, Jinyoung Kim, Chaiho Jeong, Jeongmin Lee, Yejee Lim, Ki-Hyun Baek, Jeonghoon Ha
    Journal of Bone and Mineral Metabolism.2024; 42(6): 720.     CrossRef
  • 7. Is bone mineral density a prognostic factor in postmenopausal women with luminal A breast cancer?
    Seungju Lee, Hyun Yul Kim, Youn Joo Jung, Seok-Kyung Kang, Jee Yeon Kim, Mi Sook Yun
    Korean Journal of Clinical Oncology.2023; 19(1): 27.     CrossRef
  • 8. Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study
    Helena Abreu do Valle, Paramdeep Kaur, Janice S. Kwon, Rona Cheifetz, Lesa Dawson, Gillian E. Hanley
    Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
  • 9. Osteoporotic Fractures among Selective Estrogen Receptor Modulator Users in South Korea: Analysis Using National Claims Database
    Jung-Wee Park, Young-Kyun Lee, Yangseon Choi, Yong-Chan Ha
    Journal of Bone Metabolism.2022; 29(2): 75.     CrossRef
  • 10. Fractures and long-term mortality in cancer patients: a population-based cohort study
    Carrie Ye, William D. Leslie, Saeed Al-Azazi, Lin Yan, Lisa M. Lix, Piotr Czaykowski, Harminder Singh
    Osteoporosis International.2022; 33(12): 2629.     CrossRef
  • 11. The influence of age, menstrual state and body mass index on the relation between osteopenia and osteoporosis associated with breast cancer
    Ali Abdul Hussein S. Al-Janabi
    Journal of Obstetrics and Gynaecology.2022; 42(7): 3368.     CrossRef
  • 8,317 View
  • 99 Download
  • Crossref
Risk of Osteoporotic Fractures after Thyroid-stimulating Hormone Suppression Therapy in Patients with Thyroid Cancer
Youjin Lee, Byung-Ho Yoon, Seeyoun Lee, Youn Kyung Chung, Young-Kyun Lee
J Bone Metab 2019;26(1):45-50.
Published online February 28, 2019
DOI: https://doi.org/10.11005/jbm.2019.26.1.45
Background

The effects of subclinical hyperthyroidism on fracture risk induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with thyroid cancer still remains controversial. We performed a meta-analysis and systematic review to evaluate the effects of TSH suppression therapy on osteoporotic fracture in patients with thyroid cancer.

Methods

We performed a systematic search to identify studies which included osteoporotic fractures (hip fracture and vertebral fracture) in patients on TSH suppression therapy for thyroid cancer. Main outcome measures were occurrence and risk of osteoporotic fractures including hip and vertebral fractures between patients and controls.

Results

A systematic search yielded a total of 8 studies appropriate for review which included osteoporotic fracture outcome in patients on TSH suppression therapy for thyroid cancer. Studies with larger number of subjects showed the higher risk of osteoporotic fracture in group with TSH suppression therapy, although studies with smaller sample size presented a similar risk of fracture with control group.

Conclusions

Although studies were limited by small numbers, results suggested possible association between chronic TSH suppression therapy and the increased risk of osteoporotic fractures in patients with thyroid cancer.

Citations

Citations to this article as recorded by  Crossref logo
  • 1. TSH suppression attenuates the early efficacy of zoledronic acid in osteoporosis
    Yujuan Liu, Yilei Zhang, Meiye Li, Ying Qian, Zongjing Zhang, Zhaoshun Jiang, Wei Qu
    Archives of Osteoporosis.2026;[Epub]     CrossRef
  • 2. The effect of replacement versus suppressive doses of levothyroxine on bone mineral density
    Mahmood Parham, Mohammad Bagherzadeh, Seyed Mohammad Hossein Miri Ashtiani, Bita Bitarafan, Elham Jafari, Mohammad Aghaali
    BMC Endocrine Disorders.2026;[Epub]     CrossRef
  • 3. Association between surgical extent and outcomes for low-risk 2–4 cm differentiated thyroid cancer in the 2025 ATA era: A SEER competing-risk analysis with nomogram
    Ziqiang Wang, Yangyang Xie, Weijun Zhang, Qiwei Du, Nian Liu, Xue Song
    Surgical Oncology.2026; 67: 102481.     CrossRef
  • 4. TSH suppression therapy from an individualized perspective: from mechanism to clinical decision-making
    Zhaoqing Li, Tengfei Wang, Jia Liu
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • 5. Effects of vitamin D3 and calcium supplementation on bone of young adults after thyroidectomy of differentiated thyroid carcinoma
    Lei Sun, Xiaoyun Lin, Naishi Li, Qian Zhang, Yan Jiang, Ou Wang, Weibo Xia, Xiaoping Xing, Xiaoyi Li, Mei Li
    Endocrine.2025; 88(3): 836.     CrossRef
  • 6. Risk of Osteoporotic Fractures among Patients with Thyroid Cancer: A Nationwide Population-Based Cohort Study
    Eu Jeong Ku, Won Sang Yoo, Yu Been Hwang, Subin Jang, Jooyoung Lee, Shinje Moon, Eun Kyung Lee, Hwa Young Ahn
    Endocrinology and Metabolism.2025; 40(2): 225.     CrossRef
  • 7. The effect of menopausal hormone therapy on thyroid cancer survivors from the National Health Insurance Database in South Korea cohort
    Jin-Sung Yuk, Jin Li Lee, Yeonjin Shin, Gwan Hee Han, Sang-Hee Yoon, Myoung Hwan Kim, Ji Hyun Noh, Yujin Lee, Jungbin Kim, Sam-Youl Yoon, Hyunjin Cho, Keunho Yang, Byung Noe Bae, Ki Whan Kim, Geumhee Gwak
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2025; 310: 113983.     CrossRef
  • 8. Effect of Thyroid-Stimulating Hormone Suppression on Bone Mineral Density in Patients with Differentiated Thyroid Carcinoma: A Single Center Retrospective Study
    Meihua Jin, Won Sang Yoo
    Journal of Bone Metabolism.2025; 32(3): 221.     CrossRef
  • 9. Effect of thyroid hormone replacement therapy on mortality rate in patients undergoing total or hemithyroidectomy for benign multinodular goitre
    Erik Nordenström, Jonas Ranstam, Anders Bergenfelz
    BJS Open.2024;[Epub]     CrossRef
  • 10. Impact of linkage level on inferences from big data analyses in health and medical research: an empirical study
    Bora Lee, Young-Kyun Lee, Sung Han Kim, HyunJin Oh, Sungho Won, Suk-Yong Jang, Ye Jin Jeon, Bit-Na Yoo, Jean-Kyung Bak
    BMC Medical Informatics and Decision Making.2024;[Epub]     CrossRef
  • 11. Outcomes and Trends of Treatments in High‐Risk Differentiated Thyroid Cancer
    Arash Abiri, Khodayar Goshtasbi, Sina J. Torabi, Edward C. Kuan, William B. Armstrong, Tjoson Tjoa, Yarah M. Haidar
    Otolaryngology–Head and Neck Surgery.2023; 168(4): 745.     CrossRef
  • 12. Fracture risk and assessment in adults with cancer
    Carrie Ye, William D. Leslie
    Osteoporosis International.2023; 34(3): 449.     CrossRef
  • 13. Analyses of the Association between Thyroid Cancer and Osteoporosis/Fracture Histories: A Cross-Sectional Study Using KoGES HEXA Data
    Young-Ju Jin, Chang-Myeon Song, Bum-Jung Park, Hyo-Geun Choi
    International Journal of Environmental Research and Public Health.2021; 18(9): 4732.     CrossRef
  • 14. A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol
    Eun Kyung Lee, Yea Eun Kang, Young Joo Park, Bon Seok Koo, Ki-Wook Chung, Eu Jeong Ku, Ho-Ryun Won, Won Sang Yoo, Eonju Jeon, Se Hyun Paek, Yong Sang Lee, Dong Mee Lim, Yong Joon Suh, Ha Kyoung Park, Hyo-Jeong Kim, Bo Hyun Kim, Mijin Kim, Sun Wook Kim, Ka
    Endocrinology and Metabolism.2021; 36(3): 574.     CrossRef
  • 15. Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes
    Moein Ala, Razieh Mohammad Jafari, Ahmad Reza Dehpour
    Current Diabetes Reviews.2020; 16(9): 984.     CrossRef
  • 6,412 View
  • 68 Download
  • Crossref